Banaag, Owen E.

HRN: 28-02-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
OXACILLIN 500MG (VIAL)
05/30/2026
06/06/2026
IV
160mg
Q6
Staphylococcal SKin Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines